EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacological Inhibition of the Spliceosome SF3b Complex by Pladienolide‐B Elicits Craniofacial Developmental Defects in Mouse and Zebrafish

Yukiko Hoshino, Shujie Liu iD, Toshiko Furutera, Takahiko Yamada, Daisuke Koyabu, Yuko Nukada, Masaaki Miyazawa, Tetsuya Yoda, Koichiro Ichimura, Sachiko Iseki, Junichi Tasaki iD, Masaki Takechi iD

Birth Defects Research · 2024

DOI: 10.1002/bdr2.2404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Birth Defects Research, 2024. Verfasst von Yukiko Hoshino und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Craniofacial Embryology and Oral Histology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental Universi…. Hauptthemen laut MEDLINE: Zebrafish, Spliceosomes, RNA Splicing Factors, Craniofacial Abnormalities. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mutations in genes encoding spliceosome components result in craniofacial structural defects in humans, referred to as spliceosomopathies. The SF3b complex is a crucial unit of the spliceosome, but model organisms generated through genetic modification of the complex do not perfectly mimic the phenotype of spliceosomopathies. Since the phenotypes are suggested to be determined by the extent of spliceosome dysfunction, an alternative experimental system that can seamlessly control SF3b function is needed.

Methods

To establish another experimental system for model organisms elucidating relationship between spliceosome function and human diseases, we administered Pladienolide‐B (PB), a SF3b complex inhibitor, to mouse and zebrafish embryos and assessed resulting phenotypes.

Results

PB‐treated mouse embryos exhibited neural tube defect and exencephaly, accompanied by apoptosis and reduced cell proliferation in the neural tube, but normal structure in the midface and jaw. PB administration to heterozygous knockout mice of Sf3b4 , a gene coding for a SF3b component, influenced the formation of cranial neural crest cells (CNCCs). Despite challenges in continuous PB administration and a high death rate in mice, PB was stably administered to zebrafish embryos, resulting in prolonged survival. Brain, cranial nerve, retina, midface, and jaw development were affected, mimicking spliceosomopathy phenotypes. Additionally, alterations in cell proliferation, cell death, and migration of CNCCs were detected.

Conclusions

We demonstrated that zebrafish treated with PB exhibited phenotypes similar to those observed in human spliceosomopathies. This experimental system may serve as a valuable research tool for understanding spliceosome function and human diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishSpliceosomesRNA Splicing FactorsCraniofacial AbnormalitiesNeural CrestAnimalsMiceEpoxy CompoundsMice, KnockoutApoptosisHumansCell ProliferationPhenotypeDisease Models, AnimalNeural Tube DefectsZebrafish ProteinsMacrolides

Stichwörter der Autor:innen

RNA splicingSF3b complexneural crest cellneural tube defectpladienolide‐Bspliceosomopathy

Substanzen

RNA Splicing Factorspladienolide BEpoxy CompoundsZebrafish ProteinsMacrolides

Autor:innen und Institutionen

  • Department of Molecular Craniofacial Embryology and Oral Histology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Office of Vaccines, Pharmaceuticals and Medical Devices Agency (PMDA), Japan.
  • R&D, Safety Science Research, Kao Corporation, Kawasaki, Japan.
  • Department of Anatomy and Life Structure, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Department of Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Research and Development Center for Precision Medicine, University of Tsukuba, Ibaraki, Japan.

ORCID-Profile: Shujie Liu, Junichi Tasaki, Masaki Takechi

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

Hoshino, Y., Liu, S., Furutera, T., Yamada, T., Koyabu, D., Nukada, Y., Miyazawa, M., Yoda, T., Ichimura, K., Iseki, S., Tasaki, J., & Takechi, M. (2024). Pharmacological Inhibition of the Spliceosome SF3b Complex by Pladienolide‐B Elicits Craniofacial Developmental Defects in Mouse and Zebrafish. Birth Defects Research. https://doi.org/10.1002/bdr2.2404

Vancouver

Hoshino Y, Liu S, Furutera T, Yamada T, Koyabu D, Nukada Y, et al. Pharmacological Inhibition of the Spliceosome SF3b Complex by Pladienolide‐B Elicits Craniofacial Developmental Defects in Mouse and Zebrafish. Birth Defects Research. 2024. doi:10.1002/bdr2.2404

BibTeX
@article{Hoshino2024,
  author = {Hoshino, Yukiko and Liu, Shujie and Furutera, Toshiko and Yamada, Takahiko and Koyabu, Daisuke and Nukada, Yuko and Miyazawa, Masaaki and Yoda, Tetsuya and Ichimura, Koichiro and Iseki, Sachiko and Tasaki, Junichi and Takechi, Masaki},
  title = {Pharmacological Inhibition of the Spliceosome SF3b Complex by Pladienolide‐B Elicits Craniofacial Developmental Defects in Mouse and Zebrafish},
  journal = {Birth Defects Research},
  year = {2024},
  doi = {10.1002/bdr2.2404}
}
Kostenlos starten →